Best Practice & Research Clinical Haematology
Volume 19, Issue 1 , Pages 27-34 , March 2006

Rh-immunoglobulin: Rh prophylaxis

References 

  1. Bourgeois L. Observations diverses sur la sterilite, perte de fruiot, fecondite accouchements, et maladies des femmes et enfants nouveaux-naiz. Paris; p. 1609.
  2. Diamond LK, Blackfan KD, Baty JM. Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newborn. J Pediatr. 1932;1:269–309
  3. Darrow RR. Icterus gravis (erythroblastosis neonatorum. examination of etiologic considerations). Arch Pathol. 1938;25:378–417
  4. Landsteiner K, Wiener AS. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc Soc Exp Biol Med. 1940;43:223
  5. Levine P, Katzin EM, Burnham L. Isoimmunization in pregnancy: its possible bearing on the etiology of erythroblastosis fetalis. JAMA. 1941;116:825–827
  6. Wallerstein H. Treatment of severe erythroblastosis by simultaneous removal and replacement of blood of the newborn infant. Science. 1946;103:583–584
  7. Chown B. The place of early induction in the management of erythroblastosis fetalis. Can Med Assoc J. 1958;78:252–256
  8. Liley AW. Liquor amnii analysis in management of pregnancy complicated by rhesus immunization. Am J Obstet Gynecol. 1961;82:1359
  9. Lilev AW. Intrauterine transfusion of fetus in haemolytic disease. Br Med J. 1963;2:1107
  10. Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol. 1985;153:655
  11. De Crespigny LC, Robinson HP, Quinn M, et al. Ultrasound-guided blood transfusion for severe rhesus isoimmunization. Obstet Gynecol. 1985;66:529
  12. von Dungern F. Beitrage zur Immunitatslehr. Munch Med Wochenschr. 1900;47:677
  13. Freda VJ, Gorman JG, Pollack W. Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma 2-globulin antibody preparation: a preliminary report. Transfusion. 1964;4:26
  14. Clarke CA, Donohoe WTA, McConnell RB, et al. Further experimental studies in the prevention of Rh-haemolytic disease. Br Med J. 1963;1:979
  15. Zipursky A, Israels LG. The pathogenesis and prevention of Rh immunization. Can Med Assoc J. 1967;97:1245
  16. Chown B, Duff AM, James J, et al. Prevention of primary Rh immunization: first report of the Western Canadian trial. Can Med Assoc J. 1969;100:1021
  17. Bowman JM, Chown B, Lewis M, et al. Rh-immunization during pregnancy: antenatal prophylaxis. Can Med Assoc J. 1978;118:623
  18. Samson D, Mollison PL. Effect on primary RI-immunization of delayed administration of anti-Rh. Immunology. 1975;28:349
  19. Peddle LJ. Increase of antibody titer following amniocentesis. Am J Obstet Gynecol. 1968;100:567
  20. Bowman JM, Pollock JM. Transplacental fetal hemorrhage after amniocentesis. Obstet Gynecol. 1985;66:749
  21. Pollack W, Ascari WQ, Crispin JF, et al. Studies on Rh prophylaxis II. Rh immune prophylaxis after transfusion with Rh-positive blood. Transfusion. 1971;11:340
  22. Pollack W, Ascari WQ, Kockesky RJ, et al. Studies on Rh prophylaxis. l Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion. 1971;11:333
  23. Zipursky A, Blajchman M. The Hamilton Rh prevention studies. Proceedings of the McMaster Conference on Prevention of Rh Immunization. September 28–30, 1988. vol. 36. 1979;p. 50 [Vox Sang]
  24. Hermann M, Kjellman H. Rh prophylaxis with immune globulin anti-D administered during pregnancy and after delivery. Proceedings of the McMaster Conference on Prevention of Rh Immunization. September 28–30, 1988. vol. 36. 1979;p. 50 [Vox Sang]
  25. Bartsch F, Sandberg L. Incidence of anti-D at delivery in previously non-immunized Rh-negative mothers with Rh-positive babies. Proceedings of the McMaster Conference on Prevention of Rh Immunization. September 28–30. 1977. vol. 36. 1979;p. 50 [Vox Sang]
  26. Scott IR, Beer AE, Guy LR, et al. Pathogenesis of Rh immunization in primigravidas: fetomaternal versus maternofetal bleeding. Obstet Gynecol. 1977;49:9
  27. Bowman JM, Pollock JM. Antenatal Rh prophylaxis: 28 weeks’ gestation service program. Can Med Assoc J. 1978;118–627
  28. Taylor JF. Sensitization of Rh-negative daughters by their Rh-positive mothers. N Engl J Med. 1967;276:547
  29. Cohen F, Zuelzer WW. The transplacental passage of maternal erythrocytes into the fetus. Am J Obstet Gynecol. 1965;93:566–569
  30. Bowman JM, Pollock JM. Reversal of Rh alloimmunization: fact or fancy?. Vox Sang. 1984;47:209
  31. Rivat L, Parent M, Rivat C. Adverse effects of an injection of antiRh gammaglobulin due to the presence of anti-gamma A antibodies. Presse Med. 1970;78:2072
  32. Jouvenceaux A, Adenot N, Berthoux F, et al. Lyophilised antiD gamma globulin given intravenously for the prevention of anti-Rh immunization. Rev Fr Transfus. 1969;12(supplement):341–347
  33. Hoppe HH, Mester T, Hennig W, et al. Prevention of Rh-immunization. Modified production of IgG anti-Rh for intravenous application by ion exchange chromatography (IEC). Vox Sang. 1973;25:308
  34. Bowman JM, Friesen AD, Pollock JM, et al. WinRho: Rh immune globulin prepared by ion exchange for intravenous use. Can Med Assoc J. 1980;123:1121–1127
  35. Dittman S, Roggendorf M, Durkop J, et al. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol. 1991;13:323–327
  36. Murdoch A. Irish mothers called for hepatitis C virus screening. Br Med J. 1994;308(613):614
  37. Fletcher A, Thomson A. The introduction of human monoclonal anti-D for therapeutic use. Transfus Med Rev. 1995;9:314–326
  38. Kumpel BM. In vivo studies of monoclonal anti-D and the mechanism of immune suppression. Transfus Clin Biol. 2002;9:9–14

PII: S1521-6926(05)00070-8

doi: 10.1016/j.beha.2005.03.003

Best Practice & Research Clinical Haematology
Volume 19, Issue 1 , Pages 27-34 , March 2006

Article Tools